COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2020

May 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2020-05-18

Reporting Person: Dreyer Scott (EVP & Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-18	Common Stock	M	8000	$15.9	Acquired	56441	Direct
2020-05-18	Common Stock	S	8000	$24	Disposed	48441	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-18	Stock Option (Right to Purchase)	$15.9	M	8000	Disposed	2029-01-25	Common Stock (8000)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019 and modified on March 5, 2020.

F2: 8,000 shares under the option are exercisable. The option, initially representing a right to purchase a total of 25,600 shares, vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vested and became exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.